Amedisys Home Health Of Baltimore in Forest Hill, MD - Home Health Agency

Amedisys Home Health Of Baltimore is a medicare certified home health care agency in Forest Hill, Maryland. It is located in Forest Hill at 19 Newport Drive, Ste 201, Forest Hill, Maryland 21050. You can reach out to the office of Amedisys Home Health Of Baltimore via phone at (410) 420-6412. Amedisys Home Health Of Baltimore provide healthcare services in Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide. It has the following ownership type - Proprietary.

Amedisys Home Health Of Baltimore is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this home health facility for your medical needs. The medicare CCN number for Amedisys Home Health Of Baltimore is 217045 and it was first certified by CMS in 1979 (45 years certified).

Contact Information

Amedisys Home Health Of Baltimore
19 Newport Drive, Ste 201, Forest Hill, Maryland 21050
(410) 420-6412


Home Healthcare Agency Profile

NameAmedisys Home Health Of Baltimore
Location19 Newport Drive, Ste 201, Forest Hill, Maryland
Certified ByMedicare
Services OfferedNursing Care
Physical Therapy
Occupational Therapy
Speech Pathology
Medical Social Services
Home Health Aide
Medicare ID217045
Ownership TypeProprietary
Service Area Zip Codes21001, 21005, 21009, 21014, 21015, 21017, 21028, 21034, 21040, 21047, 21050, 21078, 21084, 21087, 21111, 21120, 21132, 21154, 21160, 21161

NPI for Amedisys Home Health Of Baltimore:

Home Healthcare Agencies may have multiple NPI numbers. We have found possible NPI number/s associated with Amedisys Home Health Of Baltimore from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1245553239
Organization NameTENDER LOVING CARE HEALTH CARE SERVICES SOUTHEAST, L.L.C.
Doing Business AsAMEDISYS HOME HEALTH OF BEL AIR
Address19 Newport Dr, Suite 201, Forest Hill, MD 21050
Phone Number410-420-6412

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more Medical News

› Verified 5 days ago


NPI Number1295789360
Organization NameTENDER LOVING CARE HEALTH CARE SERVICES SOUTHEAST, LLC
Doing Business AsAMEDISYS HOME HEALTH CARE
Address134 Industry Ln Ste 3, Forest Hill, MD 21050
Phone Number410-420-6412

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more Medical News

› Verified 5 days ago

Quality Ratings:

Amedisys Home Health Of Baltimore is "Medicare-certified" which means that this home health agency is approved by Medicare and meets certain federal health and safety requirements, however, home health agencies may vary in the quality of care and services they provide to their patients. The quality ratings gives you an indication of the care Amedisys Home Health Of Baltimore give to their patients incomparison to other home health agencies. This quality rating is based on process quality measures and patient outcome measures survey conducted by CMS.

Quality Rating:

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more Medical News

› Verified 5 days ago

Process Quality Measures:

The below quality measures show how often Amedisys Home Health Of Baltimore used best practices when caring for its patients (process measures). Amedisys Home Health Of Baltimore quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often the home health team began their patients’ care in a timely manner99.795.7
How often the home health team taught patients (or their family caregivers) about their drugs99.898.6
How often the home health team checked patients’ risk of falling99.499.6
How often the home health team checked patients for depression94.197.4
How often the home health team made sure that their patients have received a flu shot for the current flu season.77.878.7
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot).79.882.2
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care93.796.4

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more Medical News

› Verified 5 days ago

Patient Outcome Quality Measures:

The below quality measures show whether patients with Amedisys Home Health Of Baltimore improved in certain important areas of care (patient outcome). Amedisys Home Health Of Baltimore quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often patients got better at walking or moving around84.279.6
How often patients got better at getting in and out of bed88.381.1
How often patients got better at bathing86.782.3
How often patients’ breathing improved89.582.8
How often patients’ wounds improved or healed after an operation96.992.3
How often patients got better at taking their drugs correctly by mouth8175
How often home health patients had to be admitted to the hospital13.415.4
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted13.613
How often physician-recommended actions to address medication issues were completely timely96.394

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more Medical News

› Verified 5 days ago

Patients' Survey and Ratings:

The patient experience of care survey collects patient (or their family or friend's) feedback about topics for which the patient is the best source of information. When choosing a home health agency, patients can use this information to find out what other patients thought about the care given by a certain home health agency. The total number of patients who responded in this survey for Amedisys Home Health Of Baltimore are 365.
Question Type:Rating by Patients
Health team gave care in a professional way
Health team communicated well with them
Health team discussed medicines, pain, and home safety
How patients rated overall care from agency

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more Medical News

› Verified 5 days ago

The patient survey data of Amedisys Home Health Of Baltimore is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percent of patients who reported that their home health team gave care in a professional way9488
Percent of patients who reported that their home health team communicated well with them8985
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them8583
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest)9084
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family8778

News Archive

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention - scheduled to take place July 22 to July 25 in Sydney, Australia - released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

Diffusion Pharmaceuticals receives new U.S. patents for trans sodium crocetinate

Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

The Clinical Research Forum has announced the winners of its third annual Top 10 Clinical Research Achievement Awards. The winning projects represent the outstanding examples of research projects that benefit the health and well-being of the general public.

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Read more News

› Verified 5 days ago

Home Healthcare Agencies in Forest Hill, MD

Amedisys Home Health Of Baltimore
Location: 19 Newport Drive, Ste 201, Forest Hill, Maryland 21050
Ratings:

Phone: (410) 420-6412    

Home Health Care

Home health care is a wide range of health care services that can be given in your home for an illness or injury. Home health care is usually less expensive, more convenient, and just as effective as care you get in a hospital or skilled nursing facility (SNF). The goal of home health care is to treat an illness or injury. Home health care helps you get better, regain your independence, and become as self-sufficient as possible.

Home Healthcare Agency Compare

Home Health Compare has information about the quality of care provided by "Medicare-certified" home health agencies throughout the nation. "Medicare-certified" means the home health agency is approved by Medicare and meets certain federal health and safety requirements. Home Health Compare can help you or your family or friends choose a quality home health agency that has the skilled home health services you need.

Home Health Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (DHHS).

NOTE: Medicare won't cover home health services provided by a home health agency that hasn't been Medicare-certified.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.